Evidence map›Paper›PMID 32131841›Full record

ArticleMalaria journal2020

Assessment of subpatent Plasmodium infection in northwestern Ethiopia.

Ashenafi Assefa, Ahmed Ali Ahmed, Wakgari Deressa, G Glenn Wilson, Amha Kebede, Hussein Mohammed, Maruon Sassine, Mebrahtom Haile, Dereje Dilu, Hiwot Teka and 9 more

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Asymptomatic/submicroscopicParasite epidemiology and control · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Antibodies Against theFrontiers in cellular and infection microbiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 10 institutions in 5 countries.

Ashenafi AssefaEthiopian Public Health Institute, Arbegnoch Street, Mail Box: 19922, Addis Ababa, Ethiopia. ashyaega@yahoo.com.
Ahmed Ali AhmedSchool of Public Health, Addis Ababa University, Addis Ababa, Ethiopia.
Wakgari DeressaSchool of Public Health, Addis Ababa University, Addis Ababa, Ethiopia.
G Glenn WilsonDepartment of Biology, University of Southern Denmark, 5230, Odense M, Denmark.
Amha KebedeAfrican Society for Laboratory Medicine, Addis Ababa, Ethiopia.
Hussein MohammedEthiopian Public Health Institute, Arbegnoch Street, Mail Box: 19922, Addis Ababa, Ethiopia.
Maruon SassineMalaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Mebrahtom HaileDisease Prevention and Control Directorate, Federal Ministry of Health, Addis Ababa, Ethiopia.
Dereje DiluDisease Prevention and Control Directorate, Federal Ministry of Health, Addis Ababa, Ethiopia.
Hiwot TekaU.S. President's Malaria Initiative, United States Agency for International Development, Addis Ababa, Ethiopia.
Matthew W MurphyMalaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, U.S. President's Malaria Initiative, Addis Ababa, Ethiopia.
Sheila SergentMalaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Eric RogierMalaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Zhou ZhiyongMalaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Brian S WakemanMalaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Chris DrakeleyLondon School of Hygiene and Tropical Medicine, London, UK.
Ya Ping ShiMalaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Lorenz Von SeidleinMahidol Oxford Research Unit, Mahidol University, Bangkok, Thailand.
Jimee HwangMalaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, U.S. President's Malaria Initiative, Atlanta, GA, USA.
Division of Parasitic Diseases and Malaria · USCenters for Disease Control and Prevention · USAddis Ababa University · ETEthiopian Public Health Institute · ETFederal Ministry of Health · ETAfrican Society for Laboratory Medicine · ETLondon School of Hygiene & Tropical Medicine · GBMahidol University · THUnited States Agency for International Development · USUniversity of Southern Denmark · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEthiopia has set a goal for malaria elimination by 2030. Low parasite density infections may go undetected by conventional diagnostic methods (microscopy and rapid diagnostic tests) and their contribution to malaria transmission varies by transmission settings. This study quantified the burden of subpatent infections from samples collected from three regions of northwest Ethiopia.

methodsSub-samples of dried blood spots from the Ethiopian Malaria Indicator Survey 2015 (EMIS-2015) were tested and compared using microscopy, rapid diagnostic tests (RDTs), and nested polymerase chain reaction (nPCR) to determine the prevalence of subpatent infection. Paired seroprevalence results previously reported along with gender, age, and elevation of residence were explored as risk factors for Plasmodium infection.

resultsOf the 2608 samples collected, the highest positive rate for Plasmodium infection was found with nPCR 3.3% (95% CI 2.7-4.1) compared with RDT 2.8% (95% CI 2.2-3.5) and microscopy 1.2% (95% CI 0.8-1.7). Of the nPCR positive cases, Plasmodium falciparum accounted for 3.1% (95% CI 2.5-3.8), Plasmodium vivax 0.4% (95% CI 0.2-0.7), mixed P. falciparum and P. vivax 0.1% (95% CI 0.0-0.4), and mixed P. falciparum and Plasmodium malariae 0.1% (95% CI 0.0-0.3). nPCR detected an additional 30 samples that had not been detected by conventional methods. The majority of the nPCR positive cases (61% (53/87)) were from the Benishangul-Gumuz Region. Malaria seropositivity had significant association with nPCR positivity [adjusted OR 10.0 (95% CI 3.2-29.4), P < 0.001].

conclusionUsing nPCR the detection rate of malaria parasites increased by nearly threefold over rates based on microscopy in samples collected during a national cross-sectional survey in 2015 in Ethiopia. Such subpatent infections might contribute to malaria transmission. In addition to strengthening routine surveillance systems, malaria programmes may need to consider low-density, subpatent infections in order to accelerate malaria elimination efforts.

Indexed as

AdolescentAdultChildChild, PreschoolCross-Sectional StudiesDisease EradicationDried Blood Spot TestingEthiopiaFemaleHumansMalaria, FalciparumMalaria, VivaxMaleMiddle AgedPlasmodium falciparumPlasmodium vivaxAsymptomatic infectionsEthiopiaMalariaSub microscopic infectionsSubpatent infections

Identifiers

PMID32131841
PMCPMC7057598
OpenAlexW3011153447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.